These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 9225889)

  • 1. Sertindole hydrochloride: a novel antipsychotic medication with a favorable side effect profile.
    Brown GR; Radford JM
    South Med J; 1997 Jul; 90(7):691-3. PubMed ID: 9225889
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A review of the safety and tolerability of sertindole.
    Hale AS
    Int Clin Psychopharmacol; 1998 Mar; 13 Suppl 3():S65-70. PubMed ID: 9690973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy, cardiac safety and tolerability of sertindole: a drug surveillance.
    Pezawas L; Quiner S; Moertl D; Tauscher J; Barnas C; Küfferle B; Wolf R; Kasper S
    Int Clin Psychopharmacol; 2000 Jul; 15(4):207-14. PubMed ID: 10954060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug safety and efficacy evaluation of sertindole for schizophrenia.
    Karamatskos E; Lambert M; Mulert C; Naber D
    Expert Opin Drug Saf; 2012 Nov; 11(6):1047-62. PubMed ID: 22992213
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Controlled, dose-response study of sertindole and haloperidol in the treatment of schizophrenia. Sertindole Study Group.
    Zimbroff DL; Kane JM; Tamminga CA; Daniel DG; Mack RJ; Wozniak PJ; Sebree TB; Wallin BA; Kashkin KB
    Am J Psychiatry; 1997 Jun; 154(6):782-91. PubMed ID: 9167505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A review of the efficacy, tolerability and safety of sertindole in clinical trials.
    Perquin L; Steinert T
    CNS Drugs; 2004; 18 Suppl 2():19-30; discussion 41-3. PubMed ID: 15461313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sertindole for schizophrenia.
    Lewis R; Bagnall A; Leitner M
    Cochrane Database Syst Rev; 2000; (2):CD001715. PubMed ID: 10796657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sertindole in the treatment of psychosis in schizophrenia: efficacy and safety.
    Tamminga CA; Mack RJ; Granneman GR; Silber CJ; Kashkin KB
    Int Clin Psychopharmacol; 1997 Feb; 12 Suppl 1():S29-35. PubMed ID: 9179641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ejaculatory dysfunction in patient with schizophrenia on sertindole.
    Jukić MK; Drmić S; Mimica N
    Psychiatr Danub; 2010 Mar; 22(1):128-31. PubMed ID: 20305609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of sertindole on QTD and TPTE.
    Nielsen J; Andersen MP; Graff C; Kanters JK; Hardahl T; Dybbro J; Struijk JJ; Meyer JM; Toft E
    Acta Psychiatr Scand; 2010 May; 121(5):385-8. PubMed ID: 20085555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of patients on sertindole treatment after failure of other antipsychotics: a retrospective analysis.
    Azorin JM; Murteira S; Hansen K; Toumi M
    BMC Psychiatry; 2008 Mar; 8():16. PubMed ID: 18366634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of sertindole in schizophrenia: a clinical review.
    Zoccali RA; Bruno A; Muscatello MR
    J Clin Psychopharmacol; 2015 Jun; 35(3):286-95. PubMed ID: 25830594
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of sertindole on QTc interval in patients with schizophrenia.
    Atmaca M; Yavuzkir M; Mermi O; Topuz M; Kanmaz E; Tezcan E
    Neurosci Lett; 2008 Sep; 442(1):1-3. PubMed ID: 18639380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sertindole for the treatment of schizophrenia.
    Azorin JM; Kaladjian A; Fakra E; Adida M
    Expert Opin Pharmacother; 2010 Dec; 11(18):3053-64. PubMed ID: 21080854
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emerging treatments in the management of schizophrenia - focus on sertindole.
    Muscatello MR; Bruno A; Pandolfo G; Micò U; Settineri S; Zoccali R
    Drug Des Devel Ther; 2010 Sep; 4():187-201. PubMed ID: 20856845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety of sertindole versus risperidone in schizophrenia: principal results of the sertindole cohort prospective study (SCoP).
    Thomas SH; Drici MD; Hall GC; Crocq MA; Everitt B; Lader MH; Le Jeunne C; Naber D; Priori S; Sturkenboom M; Thibaut F; Peuskens J; Mittoux A; Tanghøj P; Toumi M; Moore ND; Mann RD
    Acta Psychiatr Scand; 2010 Nov; 122(5):345-55. PubMed ID: 20384598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The European post-marketing observational sertindole study: an investigation of the safety of antipsychotic drug treatment.
    Kasper S; Möller HJ; Hale A
    Eur Arch Psychiatry Clin Neurosci; 2010 Feb; 260(1):59-68. PubMed ID: 19455275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sertindole in the long-term treatment of schizophrenia.
    Hale AS; Azorin JM; Lemming OM; Mæhlum E
    Int Clin Psychopharmacol; 2012 Jul; 27(4):231-7. PubMed ID: 22609816
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How much do novel antipsychotics benefit the patients?
    Kasper S
    Int Clin Psychopharmacol; 1998 Mar; 13 Suppl 3():S71-7. PubMed ID: 9690974
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Do we need another atypical antipsychotic?
    Kasper S
    Eur Neuropsychopharmacol; 2008 Aug; 18 Suppl 3():S146-52. PubMed ID: 18511242
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.